TY - JOUR
T1 - Linee guida per la diagnosi di laboratorio e istologica della malattia celiaca
AU - Tonutti, Elio
AU - Visentini, D.
AU - Bizzaro, N.
AU - Villalta, D.
AU - Bagnasco, M.
AU - Tozzoli, R.
AU - Tampoia, M.
AU - Bassetti, D.
AU - Musso, M.
AU - Liguori, M.
AU - Antico, A.
AU - Platzgummer, S.
AU - Manoni, F.
AU - Camogliano, L.
AU - Pradella, M.
AU - Villanacci, V.
AU - Ceppa, P.
AU - Fiocca, R.
PY - 2005/4
Y1 - 2005/4
N2 - The diagnosis of celiac disease is made on the basis of a patient's clinical and genetic history, the finding of specific antibodies and auto-antibodies, and the evidence of histological damage revealed by a duodenal biopsy. These guidelines were written in order to provide education and guidance for the appropriate use of serological and genetic tests, and for the correct interpretation of the different histological patterns. Differing diagnostic and explanatory steps have been described so as to respond to various needs (diagnoses, monitoring, groups at risk) and according to the age of the patients. The recommendations have been based on the authors' personal experience, medical literature, consensus reached on numerous points by the study group, and the contributions from many who participated in the discussion which followed the publication of the preliminary version of the guidelines in this same journal in 2002 and also on the website of the SIMeL. Moreover, the current version is a model of interdisciplinary work which has resulted from an effective collaboration between clinical pathologists, immunologists and surgical-pathologists.
AB - The diagnosis of celiac disease is made on the basis of a patient's clinical and genetic history, the finding of specific antibodies and auto-antibodies, and the evidence of histological damage revealed by a duodenal biopsy. These guidelines were written in order to provide education and guidance for the appropriate use of serological and genetic tests, and for the correct interpretation of the different histological patterns. Differing diagnostic and explanatory steps have been described so as to respond to various needs (diagnoses, monitoring, groups at risk) and according to the age of the patients. The recommendations have been based on the authors' personal experience, medical literature, consensus reached on numerous points by the study group, and the contributions from many who participated in the discussion which followed the publication of the preliminary version of the guidelines in this same journal in 2002 and also on the website of the SIMeL. Moreover, the current version is a model of interdisciplinary work which has resulted from an effective collaboration between clinical pathologists, immunologists and surgical-pathologists.
KW - Anti-endomysial antibodies
KW - Anti-transglutaminase antibodies
KW - Celiac disease
KW - Guidelines
KW - Small bowel biopsy
UR - http://www.scopus.com/inward/record.url?scp=33747797015&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33747797015&partnerID=8YFLogxK
M3 - Articolo
AN - SCOPUS:33747797015
VL - 1
SP - 110
EP - 122
JO - Rivista Italiana della Medicina di Laboratorio
JF - Rivista Italiana della Medicina di Laboratorio
SN - 1825-859X
IS - 2
ER -